Ramizol antibiotic can tackle drug-resistant bacteria: Study

Clostridium difficile infection which is becoming resistant to traditional antibiotics caused by drug-resistant bacteria can be treated using Antibiotic Ramizol, says a recent study.

By: Agencies | | Published: January 20, 2019 11:12 am

Antibiotic Ramizol can cure Clostridium difficile. ©Shutterstock

Researchers have now developed a new antibiotic that is heralded as a breakthrough against a lethal drug-resistant hospital superbug.

Antibiotic Ramizol was found safe and effective in addressing the Clostridium difficile (C. difficile) infection which is becoming resistant to traditional antibiotics caused by drug-resistant bacteria.

C.difficile is considered one of the most common infections acquired during hospital visits and the most likely cause of diarrhoea for patients and staff in hospitals.

It causes a deadly infection in the large intestine and is most common in people who need to take antibiotics for a long period of time.

“Cases of C.difficile disease are rising and the strains are becoming more lethal. If there is an imbalance in your intestines it can begin to grow and release toxins that attack the lining of the intestines which leads to symptoms,” said Ramiz Boulos, adjunct research associate at Flinders University in Australia.

For the study, the team gave 48 rats a high dose of a new class of antibiotic for 14 days to assess its safety.

The findings, published in the journal Scientific Reports, showed that when doses of the new antibiotic were given to rats infected with the bacteria, a significant proportion of them survived the infection.

“Our research indicates Ramizol is an extremely well-tolerated antibiotic in rats, with good microbiology and antioxidant properties. It also has high chemical stability and is scalable because of the low cost of manufacturing, which could make it a viable treatment option,” Boulos said.

In addition, a very high dose on rats showed no mortalities or side effects.
There were also no changes in mean body weight, weight gain, food consumption or food efficiency for male and female rats attributable to Ramizol.

“We believe Ramizol has the potential to be the standard of care for treating C.difficile infection and has the potential to be a blockbuster drug,” Boulos noted.

Source: IANS

Published: January 20, 2019 11:12 am

Disclaimer: TheHealthSite.com does not guarantee any specific results as a result of the procedures mentioned here and the results may vary from person to person. The topics in these pages including text, graphics, videos and other material contained on this website are for informational purposes only and not to be substituted for professional medical advice.

Placenta can prevent your baby from pregnancy complications: Study

Gene therapy can speed-up recovery post nerve damage

About The health Site

Useful Links